In-house roundup: How to manage AI applications; pharma unconcerned by NHS provision; fintech embraces open source

Counsel at Equifax, Morgan Stanley and American Express say streamlining relationships with external counsel and disclosing data sets correctly are key to prosecuting artificial intelligence patents. Read more... 

In-house sources say changes to the England and Wales Patents Court Guide setting out that health authorities must be notified in the case of an injunction for an approved therapeutic product are not a cause for concern. Read more... 

Microsoft, JPMorgan and Wells Fargo explain how the cloud, AI and data sets technologies are driving them to open source and how that change is affecting patent strategies. Read more...